Advertisement
Financial

NACL Industries Q3 FY26 Results: Net Loss ₹546L, Rights Issue ₹249Cr

PSU Connect
NACL Industries reports Q3 FY26 results: Net loss ₹546L, EPS -₹0.16, extends loan ₹55Cr to subsidiary & raises ₹249Cr via rights issue.
NACL Industries Q3 FY26 Results: Net Loss ₹546L, Rights Issue ₹249Cr

Hyderabad, January 29, 2026 – NACL Industries Limited today announced the outcome of its Board of Directors meeting. Key approvals and disclosures included the company’s un-audited standalone and consolidated financial results for Q3 and nine months ended December 31, 2025, approval of loans and investments in subsidiaries, and organizational changes.

Financial Highlights

Standalone Results (Q3 FY26 vs Q3 FY25):

  • Revenue from operations: ₹29,018 lakh (Q3 FY26) vs ₹31,821 lakh (Q3 FY25)

  • Net profit/loss: -₹546 lakh (Q3 FY26) vs -₹1,361 lakh (Q3 FY25)

  • EPS (Basic/Diluted): -₹0.16 vs -₹0.47

 

Advertisement

Consolidated Results (Q3 FY26 vs Q3 FY25):

  • Revenue from operations: ₹26,777 lakh (Q3 FY26) vs ₹40,694 lakh (Q3 FY25)

  • Net profit/loss: -₹4,672 lakh (Q3 FY26) vs -₹1,016 lakh (Q3 FY25)

  • EPS (Basic/Diluted): -₹1.68 vs -₹4.27

The financials were reviewed by S.R. Batliboi & Associates LLP and received unmodified opinions.

Board Approvals & Corporate Actions

  1. Organizational Changes:

    • Mr. Kannan Upadhyaya appointed as Senior Management Personnel (SMP) – Vice President, Marketing & Sales.

    • Mr. Ravi Kumar Mukala ceased to be SMP with effect from January 29, 2026.

  2. Loans & Investments:

    • Extension of inter-corporate loan of ₹55 crore to wholly owned subsidiary NACL Spec-Chem Limited; interest rate revised from 10% to 7.5%.

    • Investment of ₹20 crore in NACL Spec-Chem Limited via subscription to Compulsorily Convertible Debentures (CCDs).

  3. Policy Updates:

    • Approval of Code of Practices and Procedures for Fair Disclosure of Unpublished Price Sensitive Information (UPSI).

    • Policy for sharing UPSI strictly on a “need-to-know” basis with partners, collaborators, lenders, legal advisors, auditors, and other authorized parties.

  4. Regulatory Notes:

    • Fine of ₹55,000 imposed by BSE for a delay in filing related party transaction disclosures; internal controls strengthened to prevent recurrence.

    • Submission to NSE & BSE for re-classification of shares held by Algavista Greentech Pvt Ltd (Promoter Group).

  5. Corporate Actions & Rights Issue:

    • Rights issue of 32,50,851 equity shares at ₹76.7 per share, raising ~₹249 crore, primarily for debt repayment and general corporate purposes.

 

Advertisement

About NACL Industries

NACL Industries operates primarily in the farm inputs and agrochemical sector. Following acquisitions and rights issues, Coromandel International Limited (CIL) acquired a 53.08% stake, making NACL a subsidiary of CIL effective August 8, 2025.

The company’s subsidiaries include:

  • NACL Spec-Chem Limited

  • NACL Multichem Private Limited

  • LR Research Laboratories Private Limited

  • NACL Agri-Solutions Private Limited

  • Nagarjuna Agrichem (Australia) Pty Limited

  • NACL Industries (Nigeria) Limited

The associate company is Nasense Labs Private Limited, India.

Advertisement